| Key Financial Ratios of Zydus Lifesciences (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
13.80 |
14.51 |
10.66 |
6.47 |
19.90 |
|
| Diluted EPS (Rs.) |
13.80 |
14.51 |
10.66 |
6.47 |
19.90 |
|
| Cash EPS (Rs.) |
17.99 |
18.01 |
13.51 |
8.91 |
22.06 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
109.96 |
83.68 |
75.64 |
64.63 |
61.29 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
109.96 |
83.68 |
75.64 |
64.63 |
61.29 |
|
| Dividend / Share(Rs.) |
3.50 |
3.50 |
3.50 |
3.20 |
3.20 |
|
| Revenue from Operations/Share (Rs.) |
61.99 |
58.96 |
56.74 |
31.55 |
68.67 |
|
| PBDIT/Share (Rs.) |
22.19 |
21.38 |
18.11 |
8.83 |
26.87 |
|
| PBIT/Share (Rs.) |
18.00 |
17.88 |
15.25 |
6.38 |
24.71 |
|
| PBT/Share (Rs.) |
15.21 |
17.00 |
14.62 |
6.27 |
24.45 |
|
| Net Profit/Share (Rs.) |
13.80 |
14.51 |
10.65 |
6.46 |
19.90 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
35.80 |
36.25 |
31.91 |
27.98 |
39.12 |
|
| PBIT Margin (%) |
29.04 |
30.32 |
26.86 |
20.22 |
35.98 |
|
| PBT Margin (%) |
24.54 |
28.84 |
25.76 |
19.87 |
35.60 |
|
| Net Profit Margin (%) |
22.25 |
24.60 |
18.77 |
20.48 |
28.97 |
|
| Return on Networth / Equity (%) |
12.54 |
17.33 |
14.08 |
10.00 |
32.46 |
|
| Return on Capital Employed (%) |
14.07 |
16.85 |
11.63 |
8.23 |
29.10 |
|
| Return on Assets (%) |
8.53 |
10.86 |
8.96 |
5.99 |
22.83 |
|
| Total Debt/Equity (X) |
0.26 |
0.39 |
0.34 |
0.42 |
0.16 |
|
| Asset Turnover Ratio (%) |
38.34 |
44.16 |
47.76 |
29.24 |
78.80 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.39 |
1.52 |
1.27 |
0.71 |
1.52 |
|
| Quick Ratio (X) |
0.99 |
0.99 |
0.80 |
0.40 |
1.18 |
|
| Inventory Turnover Ratio (X) |
4.55 |
4.10 |
4.40 |
3.46 |
10.70 |
|
| Dividend Payout Ratio (NP) (%) |
50.71 |
24.11 |
0.00 |
49.49 |
28.13 |
|
| Dividend Payout Ratio (CP) (%) |
38.90 |
19.43 |
0.00 |
35.88 |
25.38 |
|
| Earnings Retention Ratio (%) |
49.29 |
75.89 |
0.00 |
50.51 |
71.87 |
|
| Cash Earnings Retention Ratio (%) |
61.10 |
80.57 |
0.00 |
64.12 |
74.62 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
29,920.14 |
38,722.54 |
41,241.96 |
48,157.00 |
33,326.28 |
|
| EV/Net Operating Revenue (X) |
4.71 |
6.41 |
7.10 |
14.91 |
4.74 |
|
| EV/EBITDA (X) |
13.17 |
17.69 |
22.24 |
53.26 |
12.11 |
|
| MarketCap/Net Operating Revenue (X) |
4.31 |
5.88 |
6.67 |
14.05 |
4.62 |
|
| Retention Ratios (%) |
49.28 |
75.88 |
0.00 |
50.50 |
71.86 |
|
| Price/BV (X) |
2.43 |
4.14 |
5.01 |
6.86 |
5.17 |
|
| Price/Net Operating Revenue |
4.31 |
5.88 |
6.67 |
14.05 |
4.62 |
|
| Earnings Yield |
0.05 |
0.04 |
0.03 |
0.01 |
0.06 |
|
Source : Dion Global Solutions Limited
